DrugPatentWatch Database Preview
Details for Patent: 7,252,839
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Which drugs does patent 7,252,839 protect, and when does it expire?
Patent 7,252,839 protects KYLEENA and SKYLA and is included in two NDAs.
This patent has thirty-three patent family members in twenty-six countries.
Summary for Patent: 7,252,839
| Title: | Delivery system and a manufacturing process of a delivery system |
| Abstract: | A delivery system including a body construction (7) and at least one capsule (8) containing a pharmaceutical composition, the capsule having at least a first end and a second end. The body construction (7, 12, 34) has at least two locking parts (9, 10), each locking part (9, 10) having at least a first end and a second end, the first end of each locking part (9, 10) having a surface adapted to face and cover one of the at least first and second ends of the capsule (8). The diameter of at least one of the locking parts varies along its length between the first end and the second end, and the capsule (8) is mounted between the at least two locking parts. Also disclosed is a manufacturing process of a delivery system, the system including a body construction and at least one capsule containing a pharmaceutical composition. |
| Inventor(s): | Hallinen; Esa (Lempaala{umlaut over ( )}, FI), Lyytikainen; Heikki (Naantali, FI), Jarvela; Pentti (Lahti, FI), Kivi; Ilkka (Pirkkala, FI) |
| Assignee: | Schering Oy (Turku, FI) |
| Application Number: | 10/528,237 |
|
Patent Claim Types: see list of patent claims | Composition; Dosage form; Delivery; Process; |
Drugs Protected by US Patent 7,252,839
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | KYLEENA | levonorgestrel | INTRAUTERINE DEVICE;INTRAUTERINE | 208224-001 | Sep 16, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| Bayer Hlthcare | SKYLA | levonorgestrel | INTRAUTERINE DEVICE;INTRAUTERINE | 203159-001 | Jan 9, 2013 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,252,839
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 02020869 | Sep 18, 2002 | |
| PCT Information | |||
| PCT Filed | September 04, 2003 | PCT Application Number: | PCT/FI03/00647 |
| PCT Publication Date: | April 01, 2004 | PCT Publication Number: | WO2004/026196 |
International Family Members for US Patent 7,252,839
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 387898 | Start Trial | |||
| Australia | 2003258752 | Start Trial | |||
| Brazil | 0314287 | Start Trial | |||
| Canada | 2499187 | Start Trial | |||
| China | 1310627 | Start Trial | |||
| China | 1681455 | Start Trial | |||
| Costa Rica | 7709 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
